Welcome to the international HTA database

Showing [23808 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	NIHR Health Technology Assessment programme	Apixaban for the prevention of venous thromboembolism in people undergoing elective knee and hip replacement surgery
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Idebenone (Catena) for leber's hereditary optic neuropathy - first line
2011	HAYES, Inc.	Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of long-term blood glucose lowering to normal levels in patients with diabetes mellitus type 2 - Rapid report]
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011	Belgian Health Care Knowledge Centre (KCE)	Home oxygen therapy
2011	NIHR Health Technology Assessment programme	Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation: a single technology appraisal
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal for the DMP diabetes mellitus type 1 and extraction of new, relevant recommendations]
2011	HAYES, Inc.	Brachytherapy for breast cancer
2011	NIHR Health Technology Assessment programme	Boceprevir for the treatment of genotype 1 chronic hepatitis C
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Defibrotide (Defitelio) for hepatic veno-occlusive disease in haematopoietic stem cell transplantation - first line
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Prasugrel in the treatment of acute coronary syndrome]
2011	Belgian Health Care Knowledge Centre (KCE)	Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
2011	Gesundheit Osterreich GmbH (GOeG)	[Effectiveness of measures (particularly e-medication) to reduce polypharmacy]
2011	Andalusian Health Technology Assessment Area (AETSA)	[Analysis of health and socioeconomic factors influencing the progressive increase in frequentation of hospital emergency services]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Certolizumab pegol (Cimzia) for active ankylosing spondylitis (AS) - second or third line; after intolerance or inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID)
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ezetimibe for hypercholesterolaemia]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Denosumab (Prolia) for osteoporosis in men
2011	HAYES, Inc.	Selective Estrogen Receptor Modulators (SERMs) for chemoprevention of breast cancer
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Reduction of alcohol consumption in essential hypertension - Rapid report]
2011	HAYES, Inc.	Cognitive-behavioral therapy for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Laquinimod for multiple sclerosis: relapsing-remitting - first or second line.
2011	HAYES, Inc.	Signal-Averaged Electrocardiogram (SAECG) to identify risk of ventricular tachyarrhythmias and sudden cardiac death
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Reduction of alcohol consumption in essential hypertension - Rapid report]
2011	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Pharyngeal pH monitoring by Dx-pH measurement system]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Teriflunomide for relapsing multiple sclerosis (MS) - first line
2011	HAYES, Inc.	Social skills training for autistic spectrum disorders
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of non-drug treatment strategies in patients with essential hypertension: Special diets without the primary aim of reducing weight or salt intake - Rapid report]
2011	HAYES, Inc.	Alport syndrome
2011	Andalusian Health Technology Assessment Area (AETSA)	[Inclusion of new health technologies into Spanish hospitals]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for atypical haemolytic uraemic syndrome - first line
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Stem cell transplantation for multiple myeloma]
2011	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Effectiveness and safety of electrochemotherapy tumor treatment: Systematic review and meta-analysis]
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation
2011	HAYES, Inc.	Full-field digital mammography for breast cancer screening
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Indacaterol/glycopyrronium (QVA-149) for chronic obstructive pulmonary disease
2011	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of non-drug treatment strategies in patients with diabetes mellitus type 2: increase of physical activity - Rapid report]
2011	NIHR Health Technology Assessment programme	Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	Pulse oximetry (POX) screening for congenital heart defects in newborns
2011	HAYES, Inc.	Telerehabilitation after stroke
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cessation of smoking in essential hypertension - Rapid report]
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Treatment in relapsed multiple myeloma; bortezomib, lenalidomide, thalidomide]
2011	HAYES, Inc.	Total ankle replacement
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal for the DMP diabetes mellitus type 2 and extraction of new, relevant recommendations]
2011	NIHR Health Technology Assessment programme	Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis
2011	HAYES, Inc.	Lipoprotein-associated phospholipase testing for stroke assessment in adults
2011	HAYES, Inc.	Trofile™ HIV tropism assay
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fact sheet: Screening for gestational diabetes - rapid report]
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Addendum to the final report A09-02 (benefit assessment of prasugrel)]
2011	HAYES, Inc.	Vision therapy for accommodative and vergence dysfunction
2011	HAYES, Inc.	Minimally invasive total hip arthroplasty
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011	NIHR Health Technology Assessment programme	A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of HPV test in primary screening for cervical cancer]
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine gum and nicotine lozenge
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Boceprevir - Benefit assessment according to 35a Social Code Book V (dossier assessment)]
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine nasal spray and nicotine inhaler
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Ventilation systems in operating rooms a health technology assessment]
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pirfenidone - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine patch
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal for the DMP module on heart failure and extraction of new, relevant recommendations]
2011	HAYES, Inc.	NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Stem cell transplantation for multiple myeloma: assessment of the BMT CTN 0102 study]
2010	NIHR Health Technology Assessment programme	A randomised 2x2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up
2010	NIHR Health Technology Assessment programme	Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Haemorrhoidal artery ligation. NICE interventional procedures guidance 342
2010	NIHR Health Technology Assessment programme	Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study
2010	HAYES, Inc.	Paclitaxel-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Arteriovenous crossing sheathotomy for branch retinal vein occlusion. NICE interventional procedures guidance 334
2010	NIHR Health Technology Assessment programme	Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010	HAYES, Inc.	Photodynamic therapy for actinic keratosis and squamous cell carcinoma in situ
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids as co-analgesics: review of clinical effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Endoscopic submucosal dissection of lower gastrointestinal lesions. NICE interventional procedures guidance 335
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010	HAYES, Inc.	Photodynamic therapy for nonmelanoma skin cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Transcatheter endovascular closure of perimembranous ventricular septal defect. NICE interventional procedures guidance 336
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sperm DNA fragmentation and annexin column use in assisted reproductive treatments]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure therapy for patients infected wounds: a review of the clinical and cost-effectiveness evidence and recommendations for use
2010	National Institute for Health and Care Excellence (NICE)	Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. NICE interventional procedures guidance 337
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Gefitinib for the treatment of lung cancer]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Surgical correction of hallux valgus using minimal access techniques. NICE interventional procedures guidance 332
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Levonorgestrel-releasing intrauterine device (IUD) for patients with hypermenorrhea]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Patient lifts and transfer equipment: a review of clinical and cost-effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Therapeutic endoscopic division of epidural adhesions. NICE interventional procedures guidance 333
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of serum-free light chain measurement in monoclonal gammopathy]
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[18Fluorodeoxyglucose positron emission tomography in the assessment of patients with potentially curable cancer]
2010	HAYES, Inc.	Psychosocial interventions as adjunct treatments for pediatric bipolar disorder
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chair alarms in residential care and acute care: a review of the clinical effectiveness and safety
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron emission tomography (PET): diagnostic usefulness and indications]
2010	HAYES, Inc.	Quantitative computed tomography for bone mineral density